Cancer Prevention Group Blog

Cancer Prevention Group Blog

Research Today, Cancer Prevention Tomorrow

screening of high risk populations

Bowel cancer surveillance for high-risk patients in the time of COVID-19: What have we learned?

April 2, 2021 Guest Author 0

This post was written by Annie Lincoln, Ph.D. Student within the Cancer Prevention Group at King’s College London. Annie is interested in improved colorectal cancer […]

The Ageing Soma, Cancer Evolution & Prevention

September 25, 2020 Jamie Doorbar 0

James DeGregori is a Professor of Biochemistry and Molecular Genetics at the University of Colorado. His lab seeks to understand how carcinogenic conditions promote cancer […]

The Ageing Soma, Screening and All-Cause Mortality

September 23, 2020 Jamie Doorbar 0

Paul Pharoah is Professor of Cancer Epidemiology at the University of Cambridge, where he leads research on the molecular pathology of breast and ovarian cancer […]

Best of BEST3: A (not so) hard pill to swallow- an overview of BEST3 & the Cytosponge

August 5, 2020 Judith Offman 0

The results of the BEST3 trial have just been published and the findings have exceeded even our most optimistic expectations. This trial showed that the […]

A blood test to find over 50 cancers could be the future of early diagnosis

April 9, 2020 Guest Author 0

This blog was written by Mairéad Lyons. Mairéad is a Senior Consultant to YouScreen the HPV Self-Sampling study.  She has been working in healthcare for […]

Key new evidence that CT screening for lung cancer works

February 19, 2020 Guest Author 0

Following the publication of the NELSON trial earlier this month, Dr Rintoul, University Reader in Thoracic Oncology at the University of Cambridge and Honorary Respiratory […]

Which screening guidelines are woefully inadequate?

September 20, 2019 Peter Sasieni 0

Following a high-profile article calling for a change in guidelines to make it easier for African Americans to be eligible for lung cancer screening, Prof […]

Sponging the oesophagus to detect cancer earlier

July 12, 2019 Guest Author 1

We are celebrating the end of recruitment for the BEST3 Cytosponge™ Trial. In this post the BEST3 team in London and Cambridge tell us about this […]

The Art and Peril of Communicating about Cancer Screening

June 14, 2019 Guest Author 1

In this post Hilary Robbins, Scientist at the International Agency for Research on Cancer (IARC), discuses the art of communicating scientific information accurately. Whether or […]

Managing women’s cancers in Lynch syndrome

April 5, 2019 Guest Author 1

In this post Dr Emma Crosbie, Senior Lecturer & Honorary Consultant Gynaecological Oncologist, tells us about the first ever workshop to develop international standards of […]

The future could be bright for implementation of lung cancer screening in the UK.

September 25, 2018 Guest Author 3

Blog written by Rhian Gabe, Reader in Clinical Trials at Hull York Medical School. Rhian is the statistician for the Yorkshire Lung Screening Trial (YLST) […]

Welcome to the King’s Cancer Prevention blog

This blog is supported by the Cancer Research UK Cambridge Centre Early Detection Programme

Cancer Prevention: About us

We are a group of epidemiologists and population researchers studying the causes of or early events in the development of cancer. Our aim is to be able to interfere and prevent cancer or diagnose it whilst still easy to treat.

Contact us at cancerprev@kcl.ac.uk

Follow us on Social Media

 

TWITTER FEED

Tweets by CancerPrev_KCL

Latest Posts, Tags & Comments
  • Pathology and Artificial Intelligence in BEST3
  • Bowel cancer surveillance for high-risk patients in the time of COVID-19: What have we learned?
  • Headline findings of the BEST3 Trial
  • Beyond trust: collective understanding of the common good and patient data
  • Medical research and the double-edged sword of data protection
  • Medical research and the common law of confidentiality
  • Can prediction models reduce racial/ethnic disparities in lung screening eligibility criteria?
  • Cancer Prevention Group’s 2020 Christmas reading list
  • An interview with: Dr Stuart Griffiths, Director of Research & Services at Yorkshire Cancer Research
  • Achieving cervical cancer elimination requires collective action from civil society
Barrett’s oesophagus Best 3 cancer prevention cancer screening cervical cancer cervical screening cervix Clinical research network COVID-19 Cytosponge™ ethics five minutes with HPV HPV primary screening mammography medical research Oesophageal cancer public health public policy quality assurance Sasieni scandal screening sensitivity Upper GI
  • Betty Lakop: I had the privilege of working with Louise in colposcopy clinic in St. Marys Hospital. What I will never forget…
  • Pink Promise India: Great share! Totally agree with you. Early detection of breast cancer through mammography screening leads to numerous treatment options as…
  • Beyond trust: collective understanding of the common good and patient data – Cancer Prevention Group Blog: […] the previous post, we mentioned Use My Data and Understanding Patient Data as examples of efforts to bring […]
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2021 | WordPress Theme by MH Themes